BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16619285)

  • 1. Interleukin-15 mediates protection against experimental tuberculosis: a role for NKG2D-dependent effector mechanisms of CD8+ T cells.
    Rausch A; Hessmann M; Hölscher A; Schreiber T; Bulfone-Paus S; Ehlers S; Hölscher C
    Eur J Immunol; 2006 May; 36(5):1156-67. PubMed ID: 16619285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DAP10 contributes to CD8(+) T cell-mediated cytotoxic effector mechanisms during Mycobacterium tuberculosis infection.
    Hessmann M; Rausch A; Rückerl D; Adams PS; Simon M; Gilfillan S; Colonna M; Ehlers S; Hölscher C
    Immunobiology; 2011 May; 216(5):639-47. PubMed ID: 21122940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-15 protects antigen-specific CD8+ T cell contraction after Mycobacterium bovis bacillus Calmette-Guérin infection.
    Tang C; Yamada H; Shibata K; Yoshida S; Wajjwalku W; Yoshikai Y
    J Leukoc Biol; 2009 Jul; 86(1):187-94. PubMed ID: 19389797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous IL-21 restricts CD8+ T cell expansion and is not required for tumor immunity.
    Søndergaard H; Coquet JM; Uldrich AP; McLaughlin N; Godfrey DI; Sivakumar PV; Skak K; Smyth MJ
    J Immunol; 2009 Dec; 183(11):7326-36. PubMed ID: 19915059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased NKG2D expression on CD8+ T cell is involved in immune evasion in patients with gastric cancer.
    Osaki T; Saito H; Yoshikawa T; Matsumoto S; Tatebe S; Tsujitani S; Ikeguchi M
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):382-7. PubMed ID: 17255258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-12 improves cytotoxicity of natural killer cells via upregulated expression of NKG2D.
    Zhang C; Zhang J; Niu J; Zhou Z; Zhang J; Tian Z
    Hum Immunol; 2008 Aug; 69(8):490-500. PubMed ID: 18619507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and function of NKG2D in CD4+ T cells specific for human cytomegalovirus.
    Sáez-Borderías A; Gumá M; Angulo A; Bellosillo B; Pende D; López-Botet M
    Eur J Immunol; 2006 Dec; 36(12):3198-206. PubMed ID: 17109473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression and function of NKG2D molecule on intrahepatic CD8+ T cells in chronic viral hepatitis.
    Kennedy PT; Gehring AJ; Nowbath A; Selden C; Quaglia A; Dhillon A; Dusheiko G; Bertoletti A
    J Viral Hepat; 2008 Dec; 15(12):901-9. PubMed ID: 19087227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ex vivo expansion of non-MHC-restricted cytotoxic effector cells as adoptive immunotherapy for myeloma.
    Wu JY; Ernstoff MS; Hill JM; Cole B; Meehan KR
    Cytotherapy; 2006; 8(2):141-8. PubMed ID: 16698687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of antitumor responses by genetic modification of primary human T cells with a chimeric NKG2D receptor.
    Zhang T; Barber A; Sentman CL
    Cancer Res; 2006 Jun; 66(11):5927-33. PubMed ID: 16740733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms involved in synergistic anticancer immunity of anti-4-1BB and anti-CD4 therapy.
    Choi BK; Kim YH; Kang WJ; Lee SK; Kim KH; Shin SM; Yokoyama WM; Kim TY; Kwon BS
    Cancer Res; 2007 Sep; 67(18):8891-9. PubMed ID: 17875731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of NKG2D signaling prevents the development of murine CD4+ T cell-mediated colitis.
    Ito Y; Kanai T; Totsuka T; Okamoto R; Tsuchiya K; Nemoto Y; Yoshioka A; Tomita T; Nagaishi T; Sakamoto N; Sakanishi T; Okumura K; Yagita H; Watanabe M
    Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G199-207. PubMed ID: 17962357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-21 and IL-15 cytokine DNA augments HSV specific effector and memory CD8+ T cell response.
    Rodrigues L; Nandakumar S; Bonorino C; Rouse BT; Kumaraguru U
    Mol Immunol; 2009 Apr; 46(7):1494-504. PubMed ID: 19233474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NKG2D-dependent IL-17 production by human T cells in response to an intracellular pathogen.
    Paidipally P; Periasamy S; Barnes PF; Dhiman R; Indramohan M; Griffith DE; Cosman D; Vankayalapati R
    J Immunol; 2009 Aug; 183(3):1940-5. PubMed ID: 19587005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gamma c cytokines condition the progressive differentiation of CD4+ T cells.
    Masse GX; Corcuff E; Strick-Marchand H; Guy-Grand D; Tafuri-Bladt A; Albert ML; Lantz O; Di Santo JP
    Proc Natl Acad Sci U S A; 2007 Sep; 104(39):15442-7. PubMed ID: 17855567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-15 is critical for the maintenance and innate functions of self-specific CD8(+) T cells.
    Itsumi M; Yoshikai Y; Yamada H
    Eur J Immunol; 2009 Jul; 39(7):1784-93. PubMed ID: 19544306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4+NKG2D+ T cells in Crohn's disease mediate inflammatory and cytotoxic responses through MICA interactions.
    Allez M; Tieng V; Nakazawa A; Treton X; Pacault V; Dulphy N; Caillat-Zucman S; Paul P; Gornet JM; Douay C; Ravet S; Tamouza R; Charron D; Lémann M; Mayer L; Toubert A
    Gastroenterology; 2007 Jun; 132(7):2346-58. PubMed ID: 17570210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-15 induces CD8+ T cells to acquire functional NK receptors capable of modulating cytotoxicity and cytokine secretion.
    Correia MP; Costa AV; Uhrberg M; Cardoso EM; Arosa FA
    Immunobiology; 2011 May; 216(5):604-12. PubMed ID: 20956026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-15 improves cytotoxicity of natural killer cells via up-regulating NKG2D and cytotoxic effector molecule expression as well as STAT1 and ERK1/2 phosphorylation.
    Zhang C; Zhang J; Niu J; Zhang J; Tian Z
    Cytokine; 2008 Apr; 42(1):128-36. PubMed ID: 18280748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TCR-independent cytokine stimulation induces non-MHC-restricted T cell activity and is negatively regulated by HLA class I.
    von Geldern M; Simm B; Braun M; Weiss EH; Schendel DJ; Falk CS
    Eur J Immunol; 2006 Sep; 36(9):2347-58. PubMed ID: 16909431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.